186 related articles for article (PubMed ID: 9808671)
1. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices.
Hoffman AF; Lupica CR; Gerhardt GA
J Pharmacol Exp Ther; 1998 Nov; 287(2):487-96. PubMed ID: 9808671
[TBL] [Abstract][Full Text] [Related]
2. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions.
Hoffman AF; Gerhardt GA
J Neurochem; 1998 Jan; 70(1):179-89. PubMed ID: 9422361
[TBL] [Abstract][Full Text] [Related]
3. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
Régo JC; Syringas M; Leblond B; Costentin J; Bonnet JJ
Br J Pharmacol; 1999 Sep; 128(1):51-60. PubMed ID: 10498834
[TBL] [Abstract][Full Text] [Related]
4. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study.
Hoffman AF; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):455-63. PubMed ID: 10087038
[TBL] [Abstract][Full Text] [Related]
5. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
Chen BT; Rice ME
J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
[TBL] [Abstract][Full Text] [Related]
6. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
Zahniser NR; Larson GA; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
[TBL] [Abstract][Full Text] [Related]
7. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
9. Voltage-dependency of the dopamine transporter in the rat substantia nigra.
Hoffman AF; Zahniser NR; Lupica CR; Gerhardt GA
Neurosci Lett; 1999 Jan; 260(2):105-8. PubMed ID: 10025710
[TBL] [Abstract][Full Text] [Related]
10. Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum.
Salvatore MF; Hudspeth O; Arnold LE; Wilson PE; Stanford JA; MacTutus CF; Booze RM; Gerhardt GA
Neuroscience; 2004; 123(2):481-90. PubMed ID: 14698755
[TBL] [Abstract][Full Text] [Related]
11. Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.
Sabeti J; Gerhardt GA; Zahniser NR
J Pharmacol Exp Ther; 2002 Sep; 302(3):1201-11. PubMed ID: 12183681
[TBL] [Abstract][Full Text] [Related]
12. Medial dorsal striatum is more sensitive than lateral dorsal striatum to cocaine inhibition of exogenous dopamine clearance: relation to [3H]mazindol binding, but not striosome/matrix.
Cline EJ; Adams CE; Larson GA; Gerhardt GA; Zahniser NR
Exp Neurol; 1995 Jul; 134(1):135-49. PubMed ID: 7672034
[TBL] [Abstract][Full Text] [Related]
13. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.
Hebert MA; Gerhardt GA
Brain Res; 1998 Jun; 797(1):42-54. PubMed ID: 9630504
[TBL] [Abstract][Full Text] [Related]
14. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Zhou FC; Lesch KP; Murphy DL
Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859
[TBL] [Abstract][Full Text] [Related]
15. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors.
Cass WA; Zahniser NR; Flach KA; Gerhardt GA
J Neurochem; 1993 Dec; 61(6):2269-78. PubMed ID: 8245977
[TBL] [Abstract][Full Text] [Related]
16. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.
Hoffman AF; Spivak CE; Lupica CR
ACS Chem Neurosci; 2016 Jun; 7(6):700-9. PubMed ID: 27018734
[TBL] [Abstract][Full Text] [Related]
19. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
Nirenberg MJ; Vaughan RA; Uhl GR; Kuhar MJ; Pickel VM
J Neurosci; 1996 Jan; 16(2):436-47. PubMed ID: 8551328
[TBL] [Abstract][Full Text] [Related]
20. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
